Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer.
Svetec, D
Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. [electronic resource] - The Journal of urology May 1998 - 1606-8 p. digital
Publication Type: Journal Article
0022-5347
10.1097/00005392-199805000-00052 doi
Adenocarcinoma--blood
Aged
Biopsy
False Negative Reactions
Humans
Male
Middle Aged
Predictive Value of Tests
Prostate--pathology
Prostate-Specific Antigen--analysis
Prostatectomy
Prostatic Neoplasms--blood
ROC Curve
Treatment Outcome
Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. [electronic resource] - The Journal of urology May 1998 - 1606-8 p. digital
Publication Type: Journal Article
0022-5347
10.1097/00005392-199805000-00052 doi
Adenocarcinoma--blood
Aged
Biopsy
False Negative Reactions
Humans
Male
Middle Aged
Predictive Value of Tests
Prostate--pathology
Prostate-Specific Antigen--analysis
Prostatectomy
Prostatic Neoplasms--blood
ROC Curve
Treatment Outcome